Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2965611 | Journal of Cardiovascular Disease Research | 2010 | 6 Pages |
Abstract
Endothelial dysfunction is a key event in the development of vascular disease, and it precedes clinically obvious vascular pathology. Abnormal activation of the RhoA/Rho kinase (ROCK) pathway has been found to elevate vascular tone through unbalancing the production of vasodilating and vasoconstricting substances. Inhibition of the RhoA/ROCK pathway can prevent endothelial dysfunction in a variety of pathological conditions. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of the ROCK pathway and its roles in endothelial dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Guang Yang, Ruth B. Caldwell, Lin Yao, Maritza J. Romero, Haroldo A. Toque, R. William Caldwell,